Liver Cancer

Liver Cancer

Temple's GI Cancer team is experienced in managing the entire spectrum of liver cancers. We provide patients access to many of the latest treatments — including nonsurgical alternatives involving freezing, heating or chemical ablation. Therapeutic plans are designed collaboratively by a multidisciplinary team that includes hepatologists, surgeons, medical and radiation oncologists, interventional radiologists, hematologists, gastroenterologists and pathologists.

We treat every patient as an individual and assign the most appropriate specialist to oversee their care. For example, patients with metastatic liver cancer will typically see an oncology specialist. Patients with primary liver cancer are usually seen by hepatologists who stage the cancer and gauge the timing and type of treatment.

Temple Liver Cancer Team

Abdominal Organ Transplant Surgery
Antonio Di Carlo, MD, CM, FACS, FRCSC
Andreas Karachristos, MD, PhD
Kelvin Kwan N. Lau, MD

Interventional Radiology
Gary Cohen, MD

Medical Oncology
Juhi Mittal, MD

Case Study from the Temple Digestive Disease Center

In Liver Cancer, a 1-2-3 Punch

Rocco G., 50, was diagnosed with liver cancer by his community gastroenterologist in Allentown, PA. The gastroenterologist sent Rocco to a Temple hepatologist, who in conjunction with Temple imaging specialists performed several staging tests and determined that the tumor was too large to remove surgically.

Rocco's case was reviewed by the Temple interdisciplinary liver cancer team, which determined that transarterial chemoembolization (TACE) and chemotherapy would be the best method of treating the tumor before a liver transplant. TACE and chemotherapy were begun to reduce the tumor size and stop it from spreading while Rocco waited for a liver donor. Following six months of treatment, the tumor stopped growing and Rocco received a liver transplant shortly thereafter. A year after his surgery, Rocco has made a complete recovery and is living without cancer.